Handelsbanken Fonder AB »

Kymera Therapeutics shares owned by Handelsbanken Fonder AB

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Handelsbanken Fonder AB from 13F filings

Historical chart of Handelsbanken Fonder AB investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Handelsbanken Fonder AB

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 22k 56.59
2025-06-30 $720k 17k 43.64
2025-03-31 $452k 17k 27.39
2024-12-31 $664k 17k 40.24
2024-09-30 $819k 17k 47.34
2024-06-30 $460k 15k 29.87
2023-09-30 $147k 11k 13.87
2023-06-30 $244k 11k 23.02
2023-03-31 $471k 16k 29.62
2022-12-31 $397k 16k 24.97
2022-03-31 $326k 7.7k 42.34
2021-12-31 $489k 7.7k 63.51
2021-09-30 $517k 8.8k 58.75
2021-06-30 $427k 8.8k 48.52